Denali Therapeutics Inc. (DNLI) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 flat as chipmakers fall and bank earnings roll in
- Oil prices mixed as US-Russia diesel deal hopes offset Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| (NASDAQ: DNLI) | Delayed: 18.45 -0.5 (2.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.95 | 52 Week High | $ | |||
| Open | $18.82 | 52 Week Low | $ | |||
| Day High | $19.20 | P/E | N/A | |||
| Day Low | $18.15 | EPS | $ | |||
| Volume | 830,341 | |||||
